IgG class antibodies to heat shock-induced streptococcal antigens in psoriatic patients

International Journal of Dermatology

Volumn 42, Issue 2, 2003, Pages 110-115

  Pérez Lorenzo, Rolando ^b   Zambrano Zaragoza, José Francisco ^b   Moo Castillo, Karina ^b   Luna Vázquez, Dora L ^b   Ruiz Guillermo, Leopoldo ^b   García Latorre, Ethel ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; IMMUNOGLOBULIN G ANTIBODY; STREPTOCOCCUS ANTIGEN; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G;

ANTIBODY RESPONSE; ARTICLE; CANDIDA ALBICANS; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; PSORIASIS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; STREPTOLYSIN TITER; THROAT CULTURE; ADOLESCENT; ADULT; AGED; CASE CONTROL STUDY; FEMALE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PHARYNX;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; PHARYNX; PSORIASIS; STREPTOCOCCUS PYOGENES;

EID: 0037528685     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2003.01736.x     Document Type: Article

References (39)

1. Barker JNWN. The pathophysiology of psoriasis. Lancet 1991; 338: 227.
2. Barker JNWN. Pathogenesis of psoriasis. J Dermatol 1998; 25: 778.
3. Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999; 20: 40.
4. Fernández Gutiérrez LM, Cortés Franco R, Domínguez Soto L. Psoriasis. Tratamiento de 20 casos con sulfazalazina. Dermatol Rev Mex 1993; 37: 301.
5. Ockenfels HM, Schultewolter T, Ockenfels G, et al. The antipsoriatic agent dimethylfumarate immunomodulates T-cell cytokine secretion and inhibits cytokines of the psoriatic cytokine network. Br J Dermatol 1998; 139: 390.
6. Elder JT, Henseler T, Christophers E, et al. of genes and antigens: The inheritance of psoriasis. J Invest Dermatol 1994; 103: 150S.
7. Henseler T, Christophers E. Psoriasis of the early and late onset: Characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450.
8. Woodrow JC, Dave VK, Usher N, Anderson J. The HL-A system and psoriasis. Br J Dermatol 1975; 92: 417.
9. Gottlieb AB. Immunologic mechanisms in psoriasis. J Am Acad Dermatol 1988; 18: 1376.
10. Nicolas JF, Bour H, Thivolet J, et al. Immunotherapy of psoriasis with anti-CD4 monoclonal antibodies. Arch Derm Venereol (Stockh) 1994; 74 (Suppl. 186): 180.
11. Prinz JC. Psoriasis vulgaris, streptococci and the immune system: a riddle to be solved soon. Scand J Immunol 1997; 45: 583.
12. Schön MP. Animal models of psoriasis: What can we learn from them? J Invest Dermatol 1999; 112: 405.
13. Talme T, Lund Rosell B, Sundquist KG, et al. Peptide T: A new treatment for psoriasis? A review of our experiences. Acta Derm Venereol (Stockh) 1994; 74 (Suppl. 186): 76.
14. Weistein GD, Frost P. Abnormal cell proliferation in psoriasis. J Invest Dermatol 1968; 50: 254.
15. Cunningham MW, Swerlick RA. Polyspecificity of antistreptococal monoclonal antibodies and their implications in autoimmunity. J Exp Med 1986; 164: 998.
16. Leung D, Travers JB, Giorno R, et al. Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest 1995; 96: 2106.
17. Norrlind R. Significance of infections in origination of psoriasis. Acta Rheum Scand 1954; 1: 135.
18. Swerlick RA, Cunningham MW, Hall NK. Monoclonal antibodies cross-reactive with group A streptococci and normal psoriatic human skin. J Invest Dermatol 1986; 87: 367.
19. Valdimarsson H, Baker BS, Jónsdóttir I, et al. Psoriasis: a T-cell mediated autoimmune disease induced by streptococcal superantigens. Immunol Today 1995; 16: 145.
20. Whyte HJ, Baughman RD. Acute psoriasis and streptococcal infection. Arch Dermatol 1964; 89: 350.
21. Pérez-Lorenzo R, Zambrano-Zaragoza JF, Saúl A, et al. Autoantibodies to autologous skin in guttate and plaque forms of psoriasis and cross-reaction of skin antigens with streptococcal antigens. Int J Dermatol 1998; 37: 524.
22. Villeda-Gabriel G, Santamaría-Cogollos LC, Pérez-Lorenzo R, et al. Recognition of Streptococcus pyogenes and skin autoantigens in guttate psoriasis. Arch Med Res 1998; 29: 143.
23. Rosemberg EW, Noah PW. The Koebner phenomenon and the microbial basis of psoriasis. J Am Acad Dermatol 1988; 18: 151.
24. Squiqueira L, Galimberti R, Morelli L, et al. Antibodies to proteins from Pityrosporum ovale in the sera from patients with psoriasis. Clin Exp Dermatol 1994; 19: 289.
25. Skinner RB, Rosemberg W, Noah P. Psoriasis of the palms and soles is frequently associated with oropharyngeal Candida albicans. Acta Derm Venereol (Stockh) 1994; 74 (Suppl. 186): 149.
26. Bour H, Demidem A, Garrigue JL, et al. In vitro T cell response to staphylococal enterotoxin B superantigen in chronic plaque type psoriasis. Acta Derm Venereol (Stockh) 1995; 75: 218-221.
27. Bianchi G, Buffrini L, Grignolo MC, et al. Psoriasis and lyme arthritis. Acta Derm Venereol (Stockh) 1994; 74 (Suppl. 186): 119.
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of proteins utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248.
29. Scopes RK. Cell disentegration and extraction. In: Protein purification, principles and practice. Cantor CR, ed. NY, USA: Springer-Verlag, 1988: 21-32.
30. Harlow E, Lane D. Immunoassays. In: Antibodies. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1988: 553.
31. Henderson CA, Highet AS. Acute psoriasis associated with Lancefield group C and group G cutaneous streptococcal infections. Br J Dermatol 1988; 118: 559.
32. Gross WL, Packhäuser U, Hahn G, et al. Lymphocyte activation by streptococcal antigens in psoriasis. Br J Dermatol 1977; 97: 529.
33. Baker BS, Powles AV, Malkani AK, et al. Altered cell-mediated immunity to group A haemolytic streptococcal antigens in chronic plaque psoriasis. Br J Dermatol 1991; 125: 38.
34. Cohen Tervaert WC, Esseveld H. A study of the incidence of hemolytic streptococci in the throat in patients with psoriasis vulgaris, with reference to their role in the pathogenesis of this disease. Dermatologica 1970; 140: 282.
35. Horiuchi N, Aiba S, Ozawa H, et al. Peripheral blood lymphocytes from psoriatic patients are hyporresponsive to β-streptococcal superantigens. Br J Dermatol 1998; 138: 229.
36. Quinn A, Shinnick TM, Cunningham M. Anti-Hsp65 antibodies recognize M proteins of group A streptococci. Infect Immun 1996; 64: 818.
37. Rambukkana A, Das PK, Witkamp L, et al. Antibodies to mycobacterial 65 kDa heat shock protein and other immunodominant antigens in patients with psoriasis. J Invest Dermatol 1993; 100: 87.
38. McFadden JP, Norris PG, Cerio R, et al. Heat shock protein immunoreactivity in experimentally induced polymorphic light eruption. Arch Derm Venereol (Stockh) 1994; 74: 283.
39. Puig L, Fernández Figueras MT, Ferrandiz C, et al. Epidermal expression of 65 and 72 kd heat shock proteins in psoriasis and AIDS-associated psoriasiform dermatitis. J Am Acad Dermatol 1995; 33: 985.